It would likely cause a significant reaction to the upside if in fact we were able to be witness to discussions going on between Cytodyn and various other research institutions and big pharma entities. The if/then scenarios would light a fire that would be seen forever.

We have to get that first approval or at the very least partner with someone who knows without a doubt it will happen, possibly with their heft.

I, for one, would welcome that partnership as long as we can see that the partnership includes us, at least for the first few rounds of explosive uplift.